image
Consumer Defensive - Household & Personal Products - NASDAQ - US
$ 1.045
-12.9 %
$ 131 M
Market Cap
-2.9
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one SKIN stock under the worst case scenario is HIDDEN Compared to the current market price of 1.04 USD, The Beauty Health Company is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one SKIN stock under the base case scenario is HIDDEN Compared to the current market price of 1.04 USD, The Beauty Health Company is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one SKIN stock under the best case scenario is HIDDEN Compared to the current market price of 1.04 USD, The Beauty Health Company is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart SKIN

image
$1.9$1.9$1.8$1.8$1.7$1.7$1.6$1.6$1.5$1.5$1.4$1.4$1.3$1.3$1.2$1.2$1.1$1.1$1.0$1.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
334 M REVENUE
-16.00%
-67.8 M OPERATING INCOME
48.23%
-29.1 M NET INCOME
70.94%
16.1 M OPERATING CASH FLOW
-25.82%
-6.79 M INVESTING CASH FLOW
78.44%
-158 M FINANCING CASH FLOW
-322.83%
83.5 M REVENUE
5.96%
-7.2 M OPERATING INCOME
66.53%
-10.3 M NET INCOME
43.52%
16.5 M OPERATING CASH FLOW
59.69%
-862 K INVESTING CASH FLOW
58.80%
-770 K FINANCING CASH FLOW
-277.45%
Balance Sheet The Beauty Health Company
image
Current Assets 477 M
Cash & Short-Term Investments 370 M
Receivables 27.6 M
Other Current Assets 79.4 M
Non-Current Assets 209 M
Long-Term Investments 0
PP&E 19.6 M
Other Non-Current Assets 189 M
53.97 %4.03 %11.58 %2.85 %27.56 %Total Assets$685.7m
Current Liabilities 68.2 M
Accounts Payable 21.9 M
Short-Term Debt 5.15 M
Other Current Liabilities 41.1 M
Non-Current Liabilities 566 M
Long-Term Debt 563 M
Other Non-Current Liabilities 2.72 M
3.46 %6.48 %88.82 %Total Liabilities$633.9m
EFFICIENCY
Earnings Waterfall The Beauty Health Company
image
Revenue 334 M
Cost Of Revenue 152 M
Gross Profit 182 M
Operating Expenses 250 M
Operating Income -67.8 M
Other Expenses -38.7 M
Net Income -29.1 M
350m350m300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)334m(152m)182m(250m)(68m)39m(29m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
54.53% GROSS MARGIN
54.53%
-20.27% OPERATING MARGIN
-20.27%
-8.70% NET MARGIN
-8.70%
-56.17% ROE
-56.17%
-4.24% ROA
-4.24%
-10.72% ROIC
-10.72%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis The Beauty Health Company
image
20m20m00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)(120m)(120m)(140m)(140m)20192019202020202021202120222022202320232024202420252025
Net Income -29.1 M
Depreciation & Amortization 23.7 M
Capital Expenditures -6.79 M
Stock-Based Compensation 26.7 M
Change in Working Capital 0
Others -39.2 M
Free Cash Flow 9.34 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets The Beauty Health Company
image
Wall Street analysts predict an average 1-year price target for SKIN of $1.67 , with forecasts ranging from a low of $1 to a high of $2.5 .
SKIN Lowest Price Target Wall Street Target
1 USD -4.31%
SKIN Average Price Target Wall Street Target
1.67 USD 59.49%
SKIN Highest Price Target Wall Street Target
2.5 USD 139.23%
Price
Max Price Target
Min Price Target
Average Price Target
44443333222211May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 5
6. Ownership
Insider Ownership The Beauty Health Company
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
22 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
43.7 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
SKIN STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of The Beauty Health Company (NASDAQ: SKIN) and Encourages Long-Term Investors to Contact the Firm PHILADELPHIA, April 07, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating The Beauty Health Company (NASDAQ: SKIN) (“Beauty Health”) on behalf of the company's long-term investors. globenewswire.com - 1 week ago
The Beauty Health Company (SKIN) Q4 2024 Earnings Call Transcript The Beauty Health Company (NASDAQ:SKIN ) Q4 2024 Earnings Conference Call March 12, 2025 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and Chief Executive Officer Mike Monahan - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Genuity Oliver Chen - TD Cowen Olivia Tong - Raymond James Ashley Helgans - Jefferies Jon Block - Stifel Navin Tsai - BNP Paribas Operator Good day and welcome to the Beauty Health Company Fourth Quarter and 2024 Full Year Earnings and Conference Call. [Operator Instructions] Please note this event is being recorded. seekingalpha.com - 1 month ago
BeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results LONG BEACH, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to flagship brand Hydrafacial, today announced financial results for the fourth quarter ended December 31, 2024 (“Q4 2024”). globenewswire.com - 1 month ago
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of The Beauty Health Company (NASDAQ: SKIN) and Encourages Long-Term Shareholders to Contact the Firm PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating The Beauty Health Company (NASDAQ: SKIN) (“Beauty Health”) on behalf of the company's shareholders. Click here for additional information: https://kaskelalaw.com/case/the-beauty-health-company/ Since March 2024, shares of Beauty Health's common stock have declined in value from a trading price of approximately $4.50 per share to a current trading price of below $1.75 per share, a decline of over 60% in value. The. businesswire.com - 1 month ago
BeautyHealth Appoints Stephen J. Fanning to Board of Directors LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial, appoints medical aesthetics veteran, Stephen J. Fanning, to its Board of Directors. businesswire.com - 4 months ago
BeautyHealth Releases 2024 Skintuition Report LONG BEACH, Calif.--(BUSINESS WIRE)--BeautyHealth Releases 2024 Skintuition Report. businesswire.com - 4 months ago
Glancy Prongay & Murray LLP Announces Investigation of The Beauty Health Company (SKIN) f/k/a Vesper Healthcare Acquisition Corp. NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of The Beauty Health Company (NASDAQ: SKIN) f/k/a Vesper Healthcare Acquisition Corp. concerning the Company and its directors' and officers' possible violations of state laws. If you own Beauty Health stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230. businesswire.com - 4 months ago
Beauty Health (SKIN) International Revenue Performance Explored Examine Beauty Health's (SKIN) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock. zacks.com - 5 months ago
The Beauty Health Company (SKIN) Q3 2024 Earnings Call Transcript The Beauty Health Company (NASDAQ:SKIN ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and CEO Mike Monahan - CFO Conference Call Participants Oliver Chen - TD Cowen Ashley Helgans - Jefferies Allen Gong - JPMorgan Susan Anderson - Canaccord Genuity Bruce Jackson - Benchmark Company Jon Block - Stifel Linda Bolton Weiser - DA Davidson Korinne Wolfmeyer - Piper Sandler Olivia Tong - Raymond James Operator Good day, and welcome to The Beauty Health 2024 Third Quarter Earnings Conference Call. All participants will be in listen only mode. seekingalpha.com - 5 months ago
The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates The Beauty Health Company (SKIN) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.05 per share a year ago. zacks.com - 5 months ago
BeautyHealth to Report Third Quarter 2024 Financial Results on November 12, 2024 LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial™, will report third quarter 2024 financial results on Tuesday, November 12. businesswire.com - 5 months ago
Hydrafacial Announces Video Poster Abstract Presentation at the 2024 American Society for Dermatologic Surgery's Annual Meeting (ASDS): Hydrafacial enhances the outcomes of non-ablative laser and IPL treatments LONG BEACH, Calif.--(BUSINESS WIRE)--Hydrafacial Announces Video Poster Abstract Presentation at the 2024 American Society for Dermatologic Surgery's Annual Meeting (ASDS). businesswire.com - 6 months ago
8. Profile Summary

The Beauty Health Company SKIN

image
COUNTRY US
INDUSTRY Household & Personal Products
MARKET CAP $ 131 M
Dividend Yield 0.00%
Description The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Contact 2165 Spring Street, Long Beach, CA, 90806 https://www.beautyhealth.com
IPO Date Nov. 24, 2020
Employees 769
Officers Mr. Ronald Menezes Chief Revenue Officer & Executive Officer Ms. Marla Malcolm Beck President, Chief Executive Officer & Director Ms. Carrie Caulkins Chief Marketing Officer Ms. Sheri Lewis Chief Supply Chain & Operations Officer Ms. Celeste Ortiz Chief Human Resources Officer Mr. Paul Bokota J.D. Senior Vice President & General Counsel Mr. Michael P. Monahan Chief Financial Officer